Global Plasma Derived Medicine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Plasma Derived Medicine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Plasma Derived Medicine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Plasma Derived Medicine by Country/Region, 2017, 2022 & 2028

2.2 Plasma Derived Medicine Segment by Type

2.2.1 Albumin

2.2.2 Coagulation Factor

2.2.3 Immunoglobulin

2.2.4 Others

2.3 Plasma Derived Medicine Sales by Type

2.3.1 Global Plasma Derived Medicine Sales Market Share by Type (2017-2022)

2.3.2 Global Plasma Derived Medicine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Plasma Derived Medicine Sale Price by Type (2017-2022)

2.4 Plasma Derived Medicine Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Other

2.5 Plasma Derived Medicine Sales by Application

2.5.1 Global Plasma Derived Medicine Sale Market Share by Application (2017-2022)

2.5.2 Global Plasma Derived Medicine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Plasma Derived Medicine Sale Price by Application (2017-2022)

3 Global Plasma Derived Medicine by Company

3.1 Global Plasma Derived Medicine Breakdown Data by Company

3.1.1 Global Plasma Derived Medicine Annual Sales by Company (2020-2022)

3.1.2 Global Plasma Derived Medicine Sales Market Share by Company (2020-2022)

3.2 Global Plasma Derived Medicine Annual Revenue by Company (2020-2022)

3.2.1 Global Plasma Derived Medicine Revenue by Company (2020-2022)

3.2.2 Global Plasma Derived Medicine Revenue Market Share by Company (2020-2022)

3.3 Global Plasma Derived Medicine Sale Price by Company

3.4 Key Manufacturers Plasma Derived Medicine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Plasma Derived Medicine Product Location Distribution

3.4.2 Players Plasma Derived Medicine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Plasma Derived Medicine by Geographic Region

4.1 World Historic Plasma Derived Medicine Market Size by Geographic Region (2017-2022)

4.1.1 Global Plasma Derived Medicine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Plasma Derived Medicine Annual Revenue by Geographic Region

4.2 World Historic Plasma Derived Medicine Market Size by Country/Region (2017-2022)

4.2.1 Global Plasma Derived Medicine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Plasma Derived Medicine Annual Revenue by Country/Region

4.3 Americas Plasma Derived Medicine Sales Growth

4.4 APAC Plasma Derived Medicine Sales Growth

4.5 Europe Plasma Derived Medicine Sales Growth

4.6 Middle East & Africa Plasma Derived Medicine Sales Growth

5 Americas

5.1 Americas Plasma Derived Medicine Sales by Country

5.1.1 Americas Plasma Derived Medicine Sales by Country (2017-2022)

5.1.2 Americas Plasma Derived Medicine Revenue by Country (2017-2022)

5.2 Americas Plasma Derived Medicine Sales by Type

5.3 Americas Plasma Derived Medicine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Plasma Derived Medicine Sales by Region

6.1.1 APAC Plasma Derived Medicine Sales by Region (2017-2022)

6.1.2 APAC Plasma Derived Medicine Revenue by Region (2017-2022)

6.2 APAC Plasma Derived Medicine Sales by Type

6.3 APAC Plasma Derived Medicine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Plasma Derived Medicine by Country

7.1.1 Europe Plasma Derived Medicine Sales by Country (2017-2022)

7.1.2 Europe Plasma Derived Medicine Revenue by Country (2017-2022)

7.2 Europe Plasma Derived Medicine Sales by Type

7.3 Europe Plasma Derived Medicine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Plasma Derived Medicine by Country

8.1.1 Middle East & Africa Plasma Derived Medicine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Plasma Derived Medicine Revenue by Country (2017-2022)

8.2 Middle East & Africa Plasma Derived Medicine Sales by Type

8.3 Middle East & Africa Plasma Derived Medicine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Plasma Derived Medicine

10.3 Manufacturing Process Analysis of Plasma Derived Medicine

10.4 Industry Chain Structure of Plasma Derived Medicine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Plasma Derived Medicine Distributors

11.3 Plasma Derived Medicine Customer

12 World Forecast Review for Plasma Derived Medicine by Geographic Region

12.1 Global Plasma Derived Medicine Market Size Forecast by Region

12.1.1 Global Plasma Derived Medicine Forecast by Region (2023-2028)

12.1.2 Global Plasma Derived Medicine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Plasma Derived Medicine Forecast by Type

12.7 Global Plasma Derived Medicine Forecast by Application

13 Key Players Analysis

13.1 Grifols

13.1.1 Grifols Company Information

13.1.2 Grifols Plasma Derived Medicine Product Offered

13.1.3 Grifols Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Grifols Main Business Overview

13.1.5 Grifols Latest Developments

13.2 SK Plasma

13.2.1 SK Plasma Company Information

13.2.2 SK Plasma Plasma Derived Medicine Product Offered

13.2.3 SK Plasma Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 SK Plasma Main Business Overview

13.2.5 SK Plasma Latest Developments

13.3 Fusion Health Care

13.3.1 Fusion Health Care Company Information

13.3.2 Fusion Health Care Plasma Derived Medicine Product Offered

13.3.3 Fusion Health Care Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Fusion Health Care Main Business Overview

13.3.5 Fusion Health Care Latest Developments

13.4 Biotest AG

13.4.1 Biotest AG Company Information

13.4.2 Biotest AG Plasma Derived Medicine Product Offered

13.4.3 Biotest AG Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Biotest AG Main Business Overview

13.4.5 Biotest AG Latest Developments

13.5 GC Pharma

13.5.1 GC Pharma Company Information

13.5.2 GC Pharma Plasma Derived Medicine Product Offered

13.5.3 GC Pharma Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GC Pharma Main Business Overview

13.5.5 GC Pharma Latest Developments

13.6 Baxter International

13.6.1 Baxter International Company Information

13.6.2 Baxter International Plasma Derived Medicine Product Offered

13.6.3 Baxter International Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Baxter International Main Business Overview

13.6.5 Baxter International Latest Developments

13.7 LFB

13.7.1 LFB Company Information

13.7.2 LFB Plasma Derived Medicine Product Offered

13.7.3 LFB Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 LFB Main Business Overview

13.7.5 LFB Latest Developments

13.8 Octapharma AG

13.8.1 Octapharma AG Company Information

13.8.2 Octapharma AG Plasma Derived Medicine Product Offered

13.8.3 Octapharma AG Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Octapharma AG Main Business Overview

13.8.5 Octapharma AG Latest Developments

13.9 CSL Limited

13.9.1 CSL Limited Company Information

13.9.2 CSL Limited Plasma Derived Medicine Product Offered

13.9.3 CSL Limited Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 CSL Limited Main Business Overview

13.9.5 CSL Limited Latest Developments

13.10 BPL

13.10.1 BPL Company Information

13.10.2 BPL Plasma Derived Medicine Product Offered

13.10.3 BPL Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 BPL Main Business Overview

13.10.5 BPL Latest Developments

13.11 China Biologic Products

13.11.1 China Biologic Products Company Information

13.11.2 China Biologic Products Plasma Derived Medicine Product Offered

13.11.3 China Biologic Products Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 China Biologic Products Main Business Overview

13.11.5 China Biologic Products Latest Developments

13.12 Kedrion Biopharma

13.12.1 Kedrion Biopharma Company Information

13.12.2 Kedrion Biopharma Plasma Derived Medicine Product Offered

13.12.3 Kedrion Biopharma Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Kedrion Biopharma Main Business Overview

13.12.5 Kedrion Biopharma Latest Developments

13.13 RAAS

13.13.1 RAAS Company Information

13.13.2 RAAS Plasma Derived Medicine Product Offered

13.13.3 RAAS Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 RAAS Main Business Overview

13.13.5 RAAS Latest Developments

13.14 Tiantan Bio

13.14.1 Tiantan Bio Company Information

13.14.2 Tiantan Bio Plasma Derived Medicine Product Offered

13.14.3 Tiantan Bio Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Tiantan Bio Main Business Overview

13.14.5 Tiantan Bio Latest Developments

13.15 Hualan Biological Engineering

13.15.1 Hualan Biological Engineering Company Information

13.15.2 Hualan Biological Engineering Plasma Derived Medicine Product Offered

13.15.3 Hualan Biological Engineering Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Hualan Biological Engineering Main Business Overview

13.15.5 Hualan Biological Engineering Latest Developments

13.16 BOYA Bio-Pharmaceutical

13.16.1 BOYA Bio-Pharmaceutical Company Information

13.16.2 BOYA Bio-Pharmaceutical Plasma Derived Medicine Product Offered

13.16.3 BOYA Bio-Pharmaceutical Plasma Derived Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 BOYA Bio-Pharmaceutical Main Business Overview

13.16.5 BOYA Bio-Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. Plasma Derived Medicine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Plasma Derived Medicine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Albumin

Table 4. Major Players of Coagulation Factor

Table 5. Major Players of Immunoglobulin

Table 6. Major Players of Others

Table 7. Global Plasma Derived Medicine Sales by Type (2017-2022) & (K MT)

Table 8. Global Plasma Derived Medicine Sales Market Share by Type (2017-2022)

Table 9. Global Plasma Derived Medicine Revenue by Type (2017-2022) & ($ million)

Table 10. Global Plasma Derived Medicine Revenue Market Share by Type (2017-2022)

Table 11. Global Plasma Derived Medicine Sale Price by Type (2017-2022) & (USD/MT)

Table 12. Global Plasma Derived Medicine Sales by Application (2017-2022) & (K MT)

Table 13. Global Plasma Derived Medicine Sales Market Share by Application (2017-2022)

Table 14. Global Plasma Derived Medicine Revenue by Application (2017-2022)

Table 15. Global Plasma Derived Medicine Revenue Market Share by Application (2017-2022)

Table 16. Global Plasma Derived Medicine Sale Price by Application (2017-2022) & (USD/MT)

Table 17. Global Plasma Derived Medicine Sales by Company (2020-2022) & (K MT)

Table 18. Global Plasma Derived Medicine Sales Market Share by Company (2020-2022)

Table 19. Global Plasma Derived Medicine Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Plasma Derived Medicine Revenue Market Share by Company (2020-2022)

Table 21. Global Plasma Derived Medicine Sale Price by Company (2020-2022) & (USD/MT)

Table 22. Key Manufacturers Plasma Derived Medicine Producing Area Distribution and Sales Area

Table 23. Players Plasma Derived Medicine Products Offered

Table 24. Plasma Derived Medicine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Plasma Derived Medicine Sales by Geographic Region (2017-2022) & (K MT)

Table 28. Global Plasma Derived Medicine Sales Market Share Geographic Region (2017-2022)

Table 29. Global Plasma Derived Medicine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Plasma Derived Medicine Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Plasma Derived Medicine Sales by Country/Region (2017-2022) & (K MT)

Table 32. Global Plasma Derived Medicine Sales Market Share by Country/Region (2017-2022)

Table 33. Global Plasma Derived Medicine Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Plasma Derived Medicine Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Plasma Derived Medicine Sales by Country (2017-2022) & (K MT)

Table 36. Americas Plasma Derived Medicine Sales Market Share by Country (2017-2022)

Table 37. Americas Plasma Derived Medicine Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Plasma Derived Medicine Revenue Market Share by Country (2017-2022)

Table 39. Americas Plasma Derived Medicine Sales by Type (2017-2022) & (K MT)

Table 40. Americas Plasma Derived Medicine Sales Market Share by Type (2017-2022)

Table 41. Americas Plasma Derived Medicine Sales by Application (2017-2022) & (K MT)

Table 42. Americas Plasma Derived Medicine Sales Market Share by Application (2017-2022)

Table 43. APAC Plasma Derived Medicine Sales by Region (2017-2022) & (K MT)

Table 44. APAC Plasma Derived Medicine Sales Market Share by Region (2017-2022)

Table 45. APAC Plasma Derived Medicine Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Plasma Derived Medicine Revenue Market Share by Region (2017-2022)

Table 47. APAC Plasma Derived Medicine Sales by Type (2017-2022) & (K MT)

Table 48. APAC Plasma Derived Medicine Sales Market Share by Type (2017-2022)

Table 49. APAC Plasma Derived Medicine Sales by Application (2017-2022) & (K MT)

Table 50. APAC Plasma Derived Medicine Sales Market Share by Application (2017-2022)

Table 51. Europe Plasma Derived Medicine Sales by Country (2017-2022) & (K MT)

Table 52. Europe Plasma Derived Medicine Sales Market Share by Country (2017-2022)

Table 53. Europe Plasma Derived Medicine Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Plasma Derived Medicine Revenue Market Share by Country (2017-2022)

Table 55. Europe Plasma Derived Medicine Sales by Type (2017-2022) & (K MT)

Table 56. Europe Plasma Derived Medicine Sales Market Share by Type (2017-2022)

Table 57. Europe Plasma Derived Medicine Sales by Application (2017-2022) & (K MT)

Table 58. Europe Plasma Derived Medicine Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Plasma Derived Medicine Sales by Country (2017-2022) & (K MT)

Table 60. Middle East & Africa Plasma Derived Medicine Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Plasma Derived Medicine Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Plasma Derived Medicine Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Plasma Derived Medicine Sales by Type (2017-2022) & (K MT)

Table 64. Middle East & Africa Plasma Derived Medicine Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Plasma Derived Medicine Sales by Application (2017-2022) & (K MT)

Table 66. Middle East & Africa Plasma Derived Medicine Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Plasma Derived Medicine

Table 68. Key Market Challenges & Risks of Plasma Derived Medicine

Table 69. Key Industry Trends of Plasma Derived Medicine

Table 70. Plasma Derived Medicine Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Plasma Derived Medicine Distributors List

Table 73. Plasma Derived Medicine Customer List

Table 74. Global Plasma Derived Medicine Sales Forecast by Region (2023-2028) & (K MT)

Table 75. Global Plasma Derived Medicine Sales Market Forecast by Region

Table 76. Global Plasma Derived Medicine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Plasma Derived Medicine Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Plasma Derived Medicine Sales Forecast by Country (2023-2028) & (K MT)

Table 79. Americas Plasma Derived Medicine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Plasma Derived Medicine Sales Forecast by Region (2023-2028) & (K MT)

Table 81. APAC Plasma Derived Medicine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Plasma Derived Medicine Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Europe Plasma Derived Medicine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Plasma Derived Medicine Sales Forecast by Country (2023-2028) & (K MT)

Table 85. Middle East & Africa Plasma Derived Medicine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Plasma Derived Medicine Sales Forecast by Type (2023-2028) & (K MT)

Table 87. Global Plasma Derived Medicine Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Plasma Derived Medicine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Plasma Derived Medicine Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Plasma Derived Medicine Sales Forecast by Application (2023-2028) & (K MT)

Table 91. Global Plasma Derived Medicine Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Plasma Derived Medicine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Plasma Derived Medicine Revenue Market Share Forecast by Application (2023-2028)

Table 94. Grifols Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 95. Grifols Plasma Derived Medicine Product Offered

Table 96. Grifols Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 97. Grifols Main Business

Table 98. Grifols Latest Developments

Table 99. SK Plasma Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 100. SK Plasma Plasma Derived Medicine Product Offered

Table 101. SK Plasma Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 102. SK Plasma Main Business

Table 103. SK Plasma Latest Developments

Table 104. Fusion Health Care Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 105. Fusion Health Care Plasma Derived Medicine Product Offered

Table 106. Fusion Health Care Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 107. Fusion Health Care Main Business

Table 108. Fusion Health Care Latest Developments

Table 109. Biotest AG Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 110. Biotest AG Plasma Derived Medicine Product Offered

Table 111. Biotest AG Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 112. Biotest AG Main Business

Table 113. Biotest AG Latest Developments

Table 114. GC Pharma Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 115. GC Pharma Plasma Derived Medicine Product Offered

Table 116. GC Pharma Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 117. GC Pharma Main Business

Table 118. GC Pharma Latest Developments

Table 119. Baxter International Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 120. Baxter International Plasma Derived Medicine Product Offered

Table 121. Baxter International Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 122. Baxter International Main Business

Table 123. Baxter International Latest Developments

Table 124. LFB Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 125. LFB Plasma Derived Medicine Product Offered

Table 126. LFB Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 127. LFB Main Business

Table 128. LFB Latest Developments

Table 129. Octapharma AG Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 130. Octapharma AG Plasma Derived Medicine Product Offered

Table 131. Octapharma AG Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 132. Octapharma AG Main Business

Table 133. Octapharma AG Latest Developments

Table 134. CSL Limited Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 135. CSL Limited Plasma Derived Medicine Product Offered

Table 136. CSL Limited Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 137. CSL Limited Main Business

Table 138. CSL Limited Latest Developments

Table 139. BPL Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 140. BPL Plasma Derived Medicine Product Offered

Table 141. BPL Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 142. BPL Main Business

Table 143. BPL Latest Developments

Table 144. China Biologic Products Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 145. China Biologic Products Plasma Derived Medicine Product Offered

Table 146. China Biologic Products Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 147. China Biologic Products Main Business

Table 148. China Biologic Products Latest Developments

Table 149. Kedrion Biopharma Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 150. Kedrion Biopharma Plasma Derived Medicine Product Offered

Table 151. Kedrion Biopharma Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 152. Kedrion Biopharma Main Business

Table 153. Kedrion Biopharma Latest Developments

Table 154. RAAS Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 155. RAAS Plasma Derived Medicine Product Offered

Table 156. RAAS Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 157. RAAS Main Business

Table 158. RAAS Latest Developments

Table 159. Tiantan Bio Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 160. Tiantan Bio Plasma Derived Medicine Product Offered

Table 161. Tiantan Bio Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 162. Tiantan Bio Main Business

Table 163. Tiantan Bio Latest Developments

Table 164. Hualan Biological Engineering Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 165. Hualan Biological Engineering Plasma Derived Medicine Product Offered

Table 166. Hualan Biological Engineering Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 167. Hualan Biological Engineering Main Business

Table 168. Hualan Biological Engineering Latest Developments

Table 169. BOYA Bio-Pharmaceutical Basic Information, Plasma Derived Medicine Manufacturing Base, Sales Area and Its Competitors

Table 170. BOYA Bio-Pharmaceutical Plasma Derived Medicine Product Offered

Table 171. BOYA Bio-Pharmaceutical Plasma Derived Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 172. BOYA Bio-Pharmaceutical Main Business

Table 173. BOYA Bio-Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Plasma Derived Medicine

Figure 2. Plasma Derived Medicine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Plasma Derived Medicine Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Plasma Derived Medicine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Plasma Derived Medicine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Albumin

Figure 10. Product Picture of Coagulation Factor

Figure 11. Product Picture of Immunoglobulin

Figure 12. Product Picture of Others

Figure 13. Global Plasma Derived Medicine Sales Market Share by Type in 2021

Figure 14. Global Plasma Derived Medicine Revenue Market Share by Type (2017-2022)

Figure 15. Plasma Derived Medicine Consumed in Hospitals

Figure 16. Global Plasma Derived Medicine Market: Hospitals (2017-2022) & (K MT)

Figure 17. Plasma Derived Medicine Consumed in Clinics

Figure 18. Global Plasma Derived Medicine Market: Clinics (2017-2022) & (K MT)

Figure 19. Plasma Derived Medicine Consumed in Other

Figure 20. Global Plasma Derived Medicine Market: Other (2017-2022) & (K MT)

Figure 21. Global Plasma Derived Medicine Sales Market Share by Application (2017-2022)

Figure 22. Global Plasma Derived Medicine Revenue Market Share by Application in 2021

Figure 23. Plasma Derived Medicine Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Plasma Derived Medicine Revenue Market Share by Company in 2021

Figure 25. Global Plasma Derived Medicine Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Plasma Derived Medicine Revenue Market Share by Geographic Region in 2021

Figure 27. Global Plasma Derived Medicine Sales Market Share by Region (2017-2022)

Figure 28. Global Plasma Derived Medicine Revenue Market Share by Country/Region in 2021

Figure 29. Americas Plasma Derived Medicine Sales 2017-2022 (K MT)

Figure 30. Americas Plasma Derived Medicine Revenue 2017-2022 ($ Millions)

Figure 31. APAC Plasma Derived Medicine Sales 2017-2022 (K MT)

Figure 32. APAC Plasma Derived Medicine Revenue 2017-2022 ($ Millions)

Figure 33. Europe Plasma Derived Medicine Sales 2017-2022 (K MT)

Figure 34. Europe Plasma Derived Medicine Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Plasma Derived Medicine Sales 2017-2022 (K MT)

Figure 36. Middle East & Africa Plasma Derived Medicine Revenue 2017-2022 ($ Millions)

Figure 37. Americas Plasma Derived Medicine Sales Market Share by Country in 2021

Figure 38. Americas Plasma Derived Medicine Revenue Market Share by Country in 2021

Figure 39. United States Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Plasma Derived Medicine Sales Market Share by Region in 2021

Figure 44. APAC Plasma Derived Medicine Revenue Market Share by Regions in 2021

Figure 45. China Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Plasma Derived Medicine Sales Market Share by Country in 2021

Figure 52. Europe Plasma Derived Medicine Revenue Market Share by Country in 2021

Figure 53. Germany Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Plasma Derived Medicine Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Plasma Derived Medicine Revenue Market Share by Country in 2021

Figure 60. Egypt Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Plasma Derived Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Plasma Derived Medicine in 2021

Figure 66. Manufacturing Process Analysis of Plasma Derived Medicine

Figure 67. Industry Chain Structure of Plasma Derived Medicine

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles